We are live on
!
Find out more
EAM
Eventide Asset Management Portfolio holdings
AUM
$6.05B
1-Year Est. Return
76.64%
This Fund
S&P 500
This Quarter
Est. Return
+18.78%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.71B
AUM Growth
+$688M
(+14%)
Cap. Flow
-$39.8M
Cap. Flow
% of AUM
-0.7%
Top 10 Holdings %
Top 10 Hldgs %
24.42%
Holding
257
New
40
Increased
127
Reduced
58
Closed
20
Top Buys
| 1 |
EQT Corp
EQT
|
+$26.6M |
| 2 |
Chewy
CHWY
|
+$26M |
| 3 |
Verisk Analytics
VRSK
|
+$25.3M |
| 4 |
Frontdoor
FTDR
|
+$24.3M |
| 5 |
Lam Research
LRCX
|
+$20.6M |
Top Sells
| 1 |
Celldex Therapeutics
CLDX
|
+$46.7M |
| 2 |
Micron Technology
MU
|
+$33.6M |
| 3 |
Snowflake
SNOW
|
+$29.5M |
| 4 |
Inspire Medical Systems
INSP
|
+$21.7M |
| 5 |
Evolent Health
EVH
|
+$18.3M |
Sector Composition
| 1 | Healthcare | 37.06% |
| 2 | Technology | 18.81% |
| 3 | Industrials | 18.23% |
| 4 | Consumer Discretionary | 7.45% |
| 5 | Utilities | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
EXL Service
EXLS
$4.17B
| $17.3M | 0.3% |
394,930
-2,130
| -0.5% | -$97.3K |
|
102
Rockwell Automation
ROK
$52.3B
| $16.9M | 0.3% |
50,982
+787
| +2% | +$224K |
|
103
BridgeBio Pharma
BBIO
$16.5B
| $16.6M | 0.29% |
384,231
-147,961
| -28% | -$5.38M |
|
104
Equity Residential
EQR
$25.8B
| $16.6M | 0.29% |
206,835
-183,645
| -47% | -$12.6M |
|
105
Disc Medicine
IRON
$2.87B
| $16.3M | 0.29% |
308,030
+126,212
| +69% | +$5.93M |
|
106
IDEAYA Biosciences
IDYA
$3.53B
| $16.2M | 0.28% |
771,844
| – | – |
|
107
Acadia Pharmaceuticals
ACAD
$4.36B
| $15.7M | 0.28% |
728,437
-124,408
| -15% | -$2.31M |
|
108
Xylem
XYL
$28.9B
| $14.5M | 0.25% |
112,302
+1,386
| +1% | +$168K |
|
109
Fair Isaac
FICO
$28.1B
| $14.3M | 0.25% |
7,842
+8
| +0.1% | +$15K |
|
110
Broadcom
AVGO
$1.85T
| $14.2M | 0.25% |
50,971
+19,384
| +61% | +$4.21M |
|
111
AvalonBay Communities
AVB
$27.2B
| $14M | 0.24% |
+68,675
| New | +$14M |
|
112
Revolution Medicines
RVMD
$39.3B
| $13.7M | 0.24% |
372,229
| – | – |
|
113
McCormick & Company Non-Voting
MKC
$14.2B
| $13.6M | 0.24% |
179,650
+8,599
| +5% | +$644K |
|
114
United Therapeutics
UTHR
$22.4B
| $13.6M | 0.24% |
47,241
| – | – |
|
115
American Express
AXP
$242B
| $13.3M | 0.23% |
40,710
+15,448
| +61% | +$4.35M |
|
116
Syndax Pharmaceuticals
SNDX
$2.14B
| $13.2M | 0.23% |
1,414,081
+236,019
| +20% | +$2.6M |
|
117
Pool Corp
POOL
$7.66B
| $11.8M | 0.21% |
40,390
+1,471
| +4% | +$445K |
|
118
Intuit
INTU
$77.3B
| $11.8M | 0.21% |
14,796
+2,365
| +19% | +$1.6M |
|
|
MTSR
119
DELISTED
Metsera Inc
MTSR
| $11.3M | 0.2% |
396,160
+146,160
| +58% | +$3.63M |
|
120
Home Depot
HD
$337B
| $11.2M | 0.2% |
29,203
+6,315
| +28% | +$2.29M |
|
121
Bruker
BRKR
$9.11B
| $11.2M | 0.2% |
272,324
+135,924
| +100% | +$5.25M |
|
122
S&P Global
SPGI
$130B
| $11M | 0.19% |
20,700
+2,165
| +12% | +$1.08M |
|
|
RNAM
123
DELISTED
Avidity Biosciences
RNAM
| $10.7M | 0.19% |
375,924
| – | – |
|
|
AKRO
124
DELISTED
Akero Therapeutics
AKRO
| $10.7M | 0.19% |
200,000
-534
| -0.3% | -$24.3K |
|
125
Linde
LIN
$242B
| $10.6M | 0.19% |
22,460
+283
| +1% | +$129K |
|
Similar funds
AWA
HPG
CDDEC
EMPI
RCG
WHRC
GA
JWBC